Holdings
Horizon Kinetics Medical ETF
As of Jun 30, 2026, Horizon Kinetics Medical ETF reported 30 positions worth US$17.6M. Largest: Eli Lilly And Company, Abbvie Inc. and Novartis Ag. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 2,936 | US$3.52M | −141 | Jun 30, 2026 |
| Abbvie Inc. | 6,712 | US$1.69M | −322 | Jun 30, 2026 |
| Novartis Ag | 8,406 | US$1.31M | −439 | Jun 30, 2026 |
| Johnson & Johnson | 4,200 | US$1.07M | −201 | Jun 30, 2026 |
| Alkermes Plc | 20,132 | US$1.05M | −967 | Jun 30, 2026 |
| Astrazeneca Plc | 5,015 | US$951K | −241 | Jun 30, 2026 |
| Ionis Pharmaceuticals, Inc. | 10,904 | US$865K | −524 | Jun 30, 2026 |
| Bristol-myers Squibb Company | 14,644 | US$844K | −704 | Jun 30, 2026 |
| Merck & Company, Inc. | 5,872 | US$755K | −282 | Jun 30, 2026 |
| Amgen Inc. | 2,062 | US$747K | −99 | Jun 30, 2026 |